We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Early Limited Formula Use on Breastfeeding Outcomes (ELF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00952328
Recruitment Status : Completed
First Posted : August 6, 2009
Last Update Posted : April 10, 2014
Sponsor:
Collaborator:
Stanford University
Information provided by (Responsible Party):
University of California, San Francisco

Brief Summary:
The aim of this study is to conduct a pilot randomized controlled trial of the effect of early limited formula supplementation on breastfeeding-related outcomes for infants with high early weight loss. The investigators will enroll 40 exclusively breastfeeding infants at 24-48 hours of age and will randomly assign them to early limited formula supplementation following nursing (intervention group) or to no formula feeding (control group). Both groups will receive intensive lactation support. Outcome variables will include breastfeeding status on day-of-life 8, weight nadir, breastfeeding self-efficacy, maternal satisfaction, and exclusive and partial breastfeeding at 1-3 months. The hypothesis for this study is that early limited formula supplementation might help infants with early weight loss avoid eventual weight loss ≥ 10% and associated breastfeeding problems.

Condition or disease Intervention/treatment
Breastfeeding Dietary Supplement: Nutramigen infant formula

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Effect of Early Limited Formula Use on Breastfeeding Outcomes
Study Start Date : August 2009
Primary Completion Date : April 2012
Study Completion Date : April 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Breastfeeding
U.S. FDA Resources

Arm Intervention/treatment
Experimental: Limited Formula
Participants will supplement feedings with early limited formula following nursing
Dietary Supplement: Nutramigen infant formula
Investigators will advise mothers to supplement with 10 cc of elemental formula immediately following each breastfeeding and to discontinue formula once mature milk production begins.
No Intervention: Control
Participants are instructed to continue exclusively breastfeeding; no use of formula



Primary Outcome Measures :
  1. Is infant receiving exclusively breast milk at 8 days of life? [ Time Frame: 8 days following baseline ]

Secondary Outcome Measures :
  1. Is infant receiving exclusive or partial breastfeeding at 1 month, 2 months, and 3 months? [ Time Frame: 1-3 months following baseline ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 48 Hours   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Healthy term infants (37 to 42 weeks gestation)
  • Infants who have lost 5% of their birth weight at <36 hours of age

Exclusion Criteria:

  • Infants who have received formula or water
  • Mothers who are producing mature milk supply
  • Infants receiving Level II or Level III care other than healthy term infants with routine complete blood count and blood tests pending

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00952328


Locations
United States, California
University of California, San Francisco Medical Center
San Francisco, California, United States, 94143
Sponsors and Collaborators
University of California, San Francisco
Stanford University
Investigators
Principal Investigator: Valerie Flaherman, MD, MPH University of California, San Francisco

Responsible Party: University of California, San Francisco
ClinicalTrials.gov Identifier: NCT00952328     History of Changes
Other Study ID Numbers: H49316-34032-01
5 K12 HD052 163 Development
First Posted: August 6, 2009    Key Record Dates
Last Update Posted: April 10, 2014
Last Verified: April 2014

Keywords provided by University of California, San Francisco:
breastfeeding outcomes
breastfeeding self-efficacy
infant weight loss